Intec Pharma Ltd buy tamam
Start price
21.06.18
/
50%
?3.92
Target price
04.11.19
€11.73
Performance (%)
0.00%
End price
04.11.19
-
Summary
This prediction ended on 04.11.19 with a price of -. The BUY prediction by tamam closed unchanged from the start price. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intec Pharma Ltd | - | - | - | - |
| iShares Core DAX® | -1.104% | -6.084% | 3.201% | 53.313% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 20.240% | 93.480% |
| iShares Nikkei 225® | -1.082% | -7.987% | 27.550% | 52.317% |
| iShares S&P 500 | -0.055% | 0.880% | 14.887% | 66.737% |
Comments by tamam for this prediction
In the thread Intec Pharma Ltd diskutieren
Intec , a good time to go ¨bottom-fishing¨
As for future catalysts of note, the principal one to look forward to is top-line data from the phase 3 program for AP-CD/LD by the middle of next year. The fact that over 80% of patients who finished the double-blind portion of the trial have opted in to the extension study also bodes well (to a degree).
Es gibt keinen Handelsplatz